GALEN Partners III L P files SEC Form 4 disclosures for ACURA PHARMACEUTICALS, INC. They have made 7 open-market trades across 1 company since 2009, most recently 2017-12-14.
CIK 0001034486
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | -17.9% | -9.9% | -9.9% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACUR | SELL | 2017-12-14 | 2018-01-02 | $0.10 | $439K | N/A | N/A | N/A |
| ACUR | SELL | 2014-02-21 | 2014-02-25 | $1.97 | $87K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2013-06-17 | 2013-06-19 | $2.15 | $44K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2013-05-30 | 2013-06-03 | $2.25 | $71K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2013-05-13 | 2013-05-15 | $2.33 | $427K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2013-04-17 | 2013-04-19 | $3.20 | $764K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2013-04-10 | 2013-04-11 | $2.22 | $270K | -17.9% | -9.9% | -9.9% |
| MDAS | SELL · 10b5-1 | 2009-10-08 | 2009-10-13 | $22.06 | $335K | N/A | N/A | N/A |
| MDAS | SELL · 10b5-1 | 2009-09-15 | 2009-09-17 | $22.19 | $1.2M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.